Another study showed that a conjugate of anti-EGFR VHH and hydrophilic PS IRDye700DX strongly binds to high EGFR expressing tumor cells and hardly bind to low EGFR expressing tumor cells, whereas PS IRDye700DX alone doesn’t bind to any cells (82). Here, EGFR is linked to neoplasm.